Harry Penner
Directeur/Membre du Conseil chez CELLDEX THERAPEUTICS, INC.
Fortune : 92 907 $ au 31/05/2024
Provenance du réseau au premier degré de Harry Penner
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Medical/Nursing Services | 30 | |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA.
25
| Extinct | Medical Specialties | 25 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.
20
| Extinct | Biotechnology | 20 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.
12
| Extinct | Pharmaceuticals: Major | 12 |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT.
11
| Holding Company | Pharmaceuticals: Major | 11 |
CaroGen Corp.
 CaroGen Corp. BiotechnologyHealth Technology CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT.
9
| Holding Company | Biotechnology | 9 |
QCDx LLC
 QCDx LLC Electronic Equipment/InstrumentsElectronic Technology QCDx LLC engages in the design, manufacture, and marketing of instruments, consumables, and reagents for the detection of rare cells in the blood circulation. The company was founded by Triantafyllos Tafas and Harry H. Penner in 2017 and is headquartered in Farmington, CT.
3
| Holding Company | Electronic Equipment/Instruments | 3 |
MAKScientific LLC
 MAKScientific LLC Pharmaceuticals: MajorHealth Technology MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT.
3
| Private Company | Pharmaceuticals: Major | 3 |
Omax Health, Inc.
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Harry Penner via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Treasurer Corporate Officer/Principal | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Corporate Officer/Principal | |
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Chairman Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Aarhus | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Steno Diabetes Center A/S | Chairman Chairman Director/Board Member | ||
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| Boston University | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Danmarks Farmaceutiske Universitet | College/University | Undergraduate Degree Graduate Degree Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chairman | |
| NNIT A/S | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Reagan-udall Foundation | Director/Board Member Director/Board Member | ||
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| St. John's University | College/University | Graduate Degree Undergraduate Degree | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Quinnipiac University | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University | College/University | Doctorate Degree Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 33 |
| Danemark | 16 |
| Royaume-Uni | 2 |
| Belgique | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 605 |
| Corporate Officer/Principal | 233 |
| Independent Dir/Board Member | 164 |
| Chairman | 109 |
| Chief Executive Officer | 89 |
Relations les plus connectées
| Insiders | |
|---|---|
| Suzanne H. Woolsey | 64 |
| Raj Bhikhu Parekh | 50 |
| Jonathan Leff | 45 |
| John Childs | 40 |
| Garry Neil | 38 |
| Jack Nielsen | 38 |
| Una Ryan | 38 |
| Georges Gemayel | 33 |
| Anders Hedegaard | 30 |
| Jens Jesper Ovesen | 25 |
| Thomas Dyrberg | 24 |
| John P. Richard | 24 |
| Lise Kingo | 23 |
| Carsten Hellmann | 22 |
| Herbert Conrad | 21 |
- Bourse
- Insiders
- Harry Penner
- Connexions Sociétés
